Clinical Research Of The Treatment Of Functional Ventricular Premature Beat With Shuganxiehuo Prescription

Objectives: Observation of shuganxiehuo prescription in the treatment of functional ventricular premature beat of Ganyuhuahuozheng clinical curative effect, and to explore its mechanism.Documents and Methods: Choose functional ventricular premature beat(Ganyuhuahuozheng)60 patients, with using the method of random grouping, divided into treatment group and control group in the two groups, each group 30 people.Treatment group was treated with Shuganxiehuo prescription: oral Shuganxiehuo prescription medicinal broth, A pair of medicine every day, water frying it twice, take the juice 300 ml, oral twice in the morning and evening, each 150 ml; The control group with Pure anti-arrhythmic western medicine betaloc zyban, 23.75 mg to 23.75 mg each time, 1 times a day. 4 weeks as a course of treatment. Respectively before and after treatment detection in patients with general condition, dynamic electrocardiogram(ecg) and other indicators and symptoms in patients with changes.Results: Taking Shuganxiehuo prescription treatment functional ventricular premature beat(Ganyuhuahuozheng) The treatment group symptoms improve the total effective rate was 93.33%, Control group total effective rate was 76.67%, comparison between the two groups have significant difference(P < 0.05); Total number of ventricular premature beat treatment group 24 hours to improve the total effective rate was 90%, control group total effective rate was 70%, comparison between the two groups have significant difference(P < 0.05).Conclusion: Shuganxiehuo prescription in the treatment of functional ventricular premature beat(Ganyuhuahuozheng) have a significant effect, can obviously improve the symptom of the patients and the performance of the dynamic electrocardiogram(ecg).Shuganxiehuo prescription in the treatment of functional ventricular premature beat(Ganyuhuahuozheng) with low price, good curative effect and less side effect, is worth promoting.